Endotoxins and Sterility: Different Questions

Bacterial endotoxins are components associated with the outer membrane of Gram-negative bacteria. An assay targeting them does not count living bacteria. This distinction explains why disappearance of viable microorganisms does not, by itself, demonstrate disappearance of their components.

FDA's technical guidance on endotoxins describes this material difference. Its historical terminology should not be used to make endotoxin and pyrogen universal synonyms: some pyrogenic substances do not belong to that category.

A sterility test examines whether selected units show detectable microbial growth under established conditions. A negative result is not a census of every container in the batch.

FDA's aseptic-processing guidance explains the sampling limitation and the need to demonstrate microbial recovery in the presence of the product. Interpretation depends both on how representative the examined units are and on whether the method can detect contamination.

FDA guidance updated in March 2026 states that sample composition can interfere with detection. A low value therefore needs evidence of method performance in that matrix.

The document also distinguishes purified endotoxins from native sources and considers sample storage relevant. Recovered signal depends not only on how much material was originally present, but also on how much remains detectable by the assay.

Absence of growth and endotoxin detection can coexist because the measured targets differ. Likewise, an endotoxin-directed test does not demonstrate absence of every microorganism or all pyrogens.

Correct interpretation preserves each assay's name. A general microbiology-compliant box loses information if it does not establish what was sought, in which sample and against which criterion. An analytical result should not become a universal statement about the material.

Identify the sample, date, method and acceptance criterion for each result. For endotoxins, also distinguish a quantitative determination from a limit test. For sterility, the scope of sampling and method suitability matter.

These checks identify available evidence and the question that remains open. They do not require the assays to produce the same format or permit one to replace the other.